January 2014 Life Science Industry Research Reports

Xerosis (Dry Skin) Global Clinical Trials Review, H1, 2014

Published in Jan 2014 ; US $ 2500 Onwards; Publisher: GlobalData

GlobalData’s clinical trial report, “Xerosis (Dry Skin) Global Clinical Trials Review, H1, 2014” provides data on the Xerosis (Dry Skin) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Xerosis (Dry Skin). It […]

Scabies Global Clinical Trials Review, H1, 2014

Published in Jan 2014 ; US $ 2500 Onwards; Publisher: GlobalData

GlobalData’s clinical trial report, “Scabies Global Clinical Trials Review, H1, 2014” provides data on the Scabies clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Scabies. It includes an overview of the trial […]

Bruise Global Clinical Trials Review, H1, 2014

Published in Jan 2014 ; US $ 2500 Onwards; Publisher: GlobalData

GlobalData’s clinical trial report, “Bruise Global Clinical Trials Review, H1, 2014” provides data on the Bruise clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Bruise. It includes an overview of the trial […]

Spinal Muscular Atrophy (SMA) – Pipeline Review, H1 2014

Published in Jan 2014 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Spinal Muscular Atrophy (SMA) Pipeline Review, H1 2014’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Spinal Muscular Atrophy (SMA) , complete with latest updates, and special features […]

Primary Dysmenorrhea – Pipeline Review, H1 2014

Published in Jan 2014 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Primary Dysmenorrhea Pipeline Review, H1 2014’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Primary Dysmenorrhea, complete with latest updates, and special features on late-stage and discontinued projects. […]

Lymphangioleiomyomatosis – Pipeline Review, H1 2014

Published in Jan 2014 ; US $ 2000 Onwards; Publisher: Global Markets Direct

Global Markets Direct’s, ‘Lymphangioleiomyomatosis Pipeline Review, H1 2014’, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Lymphangioleiomyomatosis, complete with latest updates, and special features on late-stage and discontinued projects. It also […]